Global revenue from the CMO/CDMO biotechnology market stands at US$ 10.2 Bn in 2022, with the worldwide market estimated to surge ahead at a CAGR growth value of 11.6% to reach a valuation of around US$ 34.1 Bn by the end of 2033. https://www.persistencemarketresearch.com/market-research/cmo-cdmo-biotechnology-market.asp